Study Notes on Depression, Chemical Imbalances, and Feminism by William Schultz and Noel Hunter

William Schultz: Clinical Psychology, Minnesota School of Professional Psychology, Eagan, Minnesota, USA
Noel Hunter: Clinical Psychology, Long Island University, Brookville, New York, USA

Popular Belief: The notion that "chemical imbalances" cause depression is widely accepted.
- However, evidence suggests this theory lacks a solid foundation.
- Isolating depression to individual biological factors undermines its psychological and social dimensions.

Psychological and Social Contributions: The review underscores the importance of factors beyond biology in understanding depression.
Feminist-Informed Theories: The authors advocate for a feminist perspective as a comprehensive explanation for depression, suggesting it accounts for social and contextual factors.

Chemical Imbalance: Refers to the theory that depression is caused by deficiencies in neurotransmitters such as serotonin, dopamine, and norepinephrine.
Biopsychosocial Model (BPS): A holistic understanding of depression encompassing biological, psychological, and social factors.
- Despite its inclusivity, criticism of this model has emerged in favor of more biologically reductive explanations.

Major Depressive Disorder: Characterized by symptoms including:
- Sadness
- Lack of energy
- Anhedonia (lack of pleasure)
- Hoplessness
- Weight changes
- Sleep disturbances
- Psychomotor agitation/retardation (Hyman, 2010)
Gender Disparities: Women are diagnosed with depression at a rate approximately 2:1 compared to men (Hurst & Genest, 1995; Weissman et al., 1996).
- Women are prescribed SSRIs twice as often as men (Currie, 2005; Pratt et al., 2011).

Origin of the Theory: Began in the 1950s with the study of drugs affecting mood, such as:
- Reserpine: Originally for hypertension; observed to induce depressive symptoms.
- Iproniazid: Initially used for tuberculosis; later found to improve depressive symptoms by increasing serotonin.
- Imipramine: Discovered to alleviate depression by inhibiting neurotransmitter reuptake.
Key Studies and Articles: Key writings from 1965 and 1967 formalized the theory, positing that neurotransmitter deficiencies cause depression (Coppen, 1967; Schildkraut, 1965).
- Clinical acceptance of this theory has resulted in a pervasive belief in its validity across disciplines and the public.

Public Belief: As of 2006, 80% of Americans believed chemical imbalances led to depression (Lebowitz et al., 2013). This belief is frequently echoed in public discourse and personal narratives.
Women’s Perspectives: Many women articulate their depression in biological terms, reflecting the widespread acceptance of this narrative. For instance:
- "It’s a chemical imbalance and beyond one’s control."
- Treatment comparisons made to diabetes emphasize biological explanations as a rationale for medication adherence (Fullagar, 2009).

Lack of Diagnostic Evidence: No clinical tests can confirm a chemical imbalance (Insel, 2015).
Antidepressant Effectiveness: The effectiveness of antidepressants has come under scrutiny:
- Although antidepressants like Prozac and Zoloft increase neurotransmitters, their actual impact compared to placebo is negligible.
- Kirsch and Sapirstein's studies suggest that while antidepressants outperform placebos in statistical terms, the clinical significance is minimal, with around 75% of placebo recipients experiencing improvement (Kirsch et al., 2002).
- Enhanced placebo effects may come from expectation influenced by side effects (Kirsch, 2010).

Reserpine's Broader Context: Evidence suggesting reserpine induces depression has been critically reviewed (Baumeister et al., 2003), revealing inconsistencies in reporting and a lack of support for the theory.
- Placebo-controlled trials conducted showed no consistent depressogenic effects in healthy participants (Baumeister et al., 2003).
Confounding Factors: Investigations into chemicals that reduce neurotransmitter levels found no correlation with depression (Ruhe et al., 2007).
Therapeutic Paradox: Both SSRIs and SSREs (like Tianeptine) can yield similar therapeutic outcomes despite differing mechanisms, undermining strict neurotransmitter deficiency claims (Kirsch, 2010).

Intra-Individual Focus: Feminist theorists argue that depression is often linked to oppression rather than purely biological factors.
- Historical Context: The feminist movement in the 1970s challenged prevailing psychological perspectives, emphasizing societal oppression's role in mental health.
Contextual Understanding: Emphasis on the socio-political environment and its impact on women's mental health seeks to address the systemic context of depression.
Critique of Dominant Narratives: Feminist discourse reframes how mental health issues are perceived, urging against medicalization that overlooks societal causes of emotional distress (Hurst & Genest, 1995).

Empowerment vs. Disempowerment: Current medical narratives often disempower women by attributing their emotional states solely to chemistry rather than recognizing social injustices.
Negative Prognostic Impact: Emphasizing biological causes can foster pessimism regarding treatment outcomes, which counters the empowerment necessary for recovery (Lebowitz, 2014).
- Expectancy and belief in control are crucial factors in patient outcomes (Alladin, 2013).
Call for Feminist Approaches: The authors advocate for therapeutic frameworks that empower women and address external contributing factors rather than solely focusing on biological deficits.

Alladin, A. (2013). The power of belief and expectancy in understanding and management of depression. American Journal of Clinical Hypnosis, 55(3), 249–271.
Andrews, P. W., et al. (2015). Is serotonin an upper or downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neuroscience & Biobehavioral Reviews, 51, 164–188.
Other references are available in the original text but are not fully listed here for brevity.